New Review Published “The role of MDM2 and MDM4 in breast cancer development and prevention”

Great news, we have had a co-author review published in the Journal of Molecular and Cellular Biology. You can check out the full review here. Abstract The major cause of death from breast cancer is not the primary tumour, but relapsing, drug-resistant, metastatic disease. Identifying factors that contribute to aggressive cancer offers important leads for […]

Read More New Review Published “The role of MDM2 and MDM4 in breast cancer development and prevention”

New Publication: Clinical Overview of MDM2/X-Targeted Therapies

Great news, we have a new Mini-Review published in Frontiers Oncology entitledĀ “Clinical Overview of MDM2/X-Targeted Therapies“, which is apart of the Research TopicĀ Human tumor-derived p53 mutants: a growing family of oncoproteins Here is a little snippet from the Abstract to wet your appetite! MDM2 and MDMX are the primary negative regulators of p53, which under […]

Read More New Publication: Clinical Overview of MDM2/X-Targeted Therapies